1. Ada, Gordon L. Strategies in Vaccine Design. R.G. Landes and Company; Austin, 1994 (145-48).
2. CDC. Hepatitis B virus: a comprehensive strategy for eliminating transmission in the United States through universal childhood vaccination. Recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR 1991;40(RR-13): 1-25.
3. CDC. Immunization of health-care workers. Recommendations of the Advisory Committee on Immunization Practices (ACIP) and the Hospital Infection Control Practices Advisory Committee (HICPAC). MMWR 1997;46(RR-18):1-42.
4. CDC. Immunization of adolescents. Recommendations of the Advisory Committee on Immunization Practices, the American Academy of Pediatrics, the American Academy of Family Physicians, and the American Medical Association. MMWR 1996;45(RR-13):1-16.
5. CDC. "The Pink Book" -- Epidemiology and Prevention of Vaccine-Preventable Diseases, 1999.
6. CDC. Update: recommendations to prevent hepatitis B virus transmission-United States. MMWR 1995;44:574_5.
7. Chengalvala, Murty V. et., al. "Enhanced Immunogenicity of Hepatits B Surface Antigen by Insertion of a Helper T Cell Epitope From Tetanus Toxoid" in Vaccine 1999; 17: 1035-1041.
8. Couillin, I. et. al. "Specific Vaccine Therapy in Chronic Hepatitis B: Induction of T Cell Proliferative Responses Specific for Envelope Antigens" in The Journal of Infectious Diseases 1999 July; 180: 15-26.
9. Da Villa, G. et. al. "Long-Term Epidemiological Survey of Hepatitis B Virus Infection in a Hyperendemic Area (Afragola, southern Italy): Results of a Pilot Vaccination Program" in Res. Virology 1998; 149: 263-270.
10. Evans AS, Brachman PS, eds. Viral Infections of Humans. Epidemiology and Control. 3rd edition. New York, NY: Plenum Medical Book Company, 1998.
11. Farber E, Phillips FT, and Kaufman WA (eds). Pathogenesis of Liver Disease. Los Angeles: Williams and Wilkins, 1987.
12. Gregoriadis, Gregory et. al. Vaccines: New Generation Immunological Adjuvants. Plenum Press; New York, 1995 (153-60).
13. Hallauer J. VHPB: summary of strategies and recommendations. Vaccine, 13, S61-3, 1995.
14. Hallauer, Johannes. "VHPB: Summary of Strategies and Recommendations" in Vaccine 1999; (Supplement 1): S61-S63.
15. Jilg, W. et. al. "Clinical Evaluation of a Recombinant Hepatitis B Vaccine" in The Lancet 1984 November 24: 1174-75.
16. Lemon, Stanley M. and David L. Thomas. "Vaccines to Prevent Viral Hepatitis" in The New England Journal of Medicine 1997 January 16; 336 (3): 196-204.
17. Levitz RE, Cooper BW, Regan HC. Immunization with high-dose intradermal recombinant hepatitis B vaccine in healthcare workers who failed to respond to intramuscular vaccination. Infect Cont Hosp Epid 1995;16:88-91.
18. Mahoney F. Update on disgnosis, management, and prevention of hepatitis B virus infection. Clin Micro Rev 1999;12:351-66.
19. Mahoney, Franics J. and Mark Kane. "Hepatitis B Vaccine" Chapter 10 in Vaccines, 3rd ed. Stanley A. Plotnick and Walter A. Orenstein, eds. W.B. Saunders Company; Philadelphia, 1999 (159-82).
20. Michel, Marie-Louise et. al. "Synthesis in Animal Cells of Hepatitis B Surface Antigen Particles Carrying a Receptor for Polymerized Human Serum Albumin" in Proceedings of the National Academy of Science, USA 1984 December; 81: 7708-7712.
21. Orenstein WA, Hadler S, Wharton M. Trends in vaccine-preventable diseases. Semin Pediatr Infect Dis 1997;8:23-33.
22. Peter G, ed. 1997 Red Book: Report of the Committee on Infectious Diseases. 24th ed. Elk Grove Village, IL: American Academy of Pediatrics, 1997.
23. Plotkin SA, Orenstein WA, eds. Vaccines. 3nd edition. Philadelphia: W.B. Saunders Company, 1994.
24. Valenzuela, Pablo et. al. "Synthesis and Assembly of Hepatitis B Virus Surface Antigen Particles in Yeast" in Nature 1982 July 22; 298: 347-50.
25. Yap I and Chan SH. A new pre-S containing recombinant hepatitis B vaccine and its effect on non-responders: a preliminary observation. Ann Acad Med Singapore, 25, 120-2, 1996.
26. World Health Organization. Expanded Programme on Immunization: Hepatitis B Vaccine--Making Global Progress. Update, October 1996.
27. Wu JS, Hwang LY, Goodman KJ, Beasley RP. Hepatitis B vaccination in high-risk infants: 10-year follow-up. J Infect Dis 1999;179:1319-25.
http://www.cdc.gov
MMWR January 15, 1999/ 48 (01): 8-16.
MMWR September 10, 1999/ 48 (35): 780-82. "Questions and Answers about Hepatitis B and the Vaccine that Protects You"
"Viral Hepatitis B: Fact Sheet"
"Viral Hepatitis B: Frequently Asked Questions"
"Viral Hepatitis B: Recommendations"http://www.hepnet.com
"The Hepatitis Information Network"http://www.imunize.org
"Questions Frequently Asked About Hepatitis B"http://www.merck.com
"Products: COMVAX [haemophilus b conjugate (meningococcal protein conjugate) and Hepatitis B (recombinant) vaccine]"http://www.psigroup.com
"Two-Dose Hepatitis B Vaccine, Recombivax HB, Approved for Adolescents"http://www.sb.com
"U.S. Prescribing Information for Energix-B"http://www.who.int
"Geographic Pattern of Hepatitis B Prevalence"
"Fact Sheets: Hepatitis B (November 1998)"
"Hepatitis B Vaccine and MS"
"Qs and As on Thimerosal (July 1999)"
Epidemiology Virus Pathology and Treatment
The Vaccine The Vaccine Future Vaccine Issues
References Back to Front Links